Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 96 (4), e5641

Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis


Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis

Tadesse Melaku Abegaz et al. Medicine (Baltimore).


Background: Hypertension drives the global burden of cardiovascular disease and its prevalence is estimated to increase by 30% by the year 2025. Nonadherence to chronic medication regimens is common; approximately 43% to 65.5% of patients who fail to adhere to prescribed regimens are hypertensive patients. Nonadherence to medications is a potential contributing factor to the occurrence of concomitant diseases.

Objective: This systematic review applied a meta-analytic procedure to investigate the medication nonadherence in adult hypertensive patients.

Methods: Original research studies, conducted on adult hypertensive patients, using the 8-item Morisky medication adherence scale (MMAS-8) to assess the medication adherence between January 2009 and March 2016 were included. Comprehensive search strategies of 3 databases and MeSH keywords were used to locate eligible literature. Study characteristics, participant demographics, and medication adherence outcomes were recorded. Effect sizes for outcomes were calculated as standardized mean differences using random-effect model to estimate overall mean effects.

Results: A total of 28 studies from 15 countries were identified, in total comprising of 13,688 hypertensive patients, were reviewed. Of 25 studies included in the meta-analysis involving 12,603 subjects, a significant number (45.2%) of the hypertensive patients and one-third (31.2%) of the hypertensive patients with comorbidities were nonadherent to medications. However, a higher proportion (83.7%) of medication nonadherence was noticed in uncontrolled blood pressure (BP) patients. Although a higher percentage (54%) of nonadherence to antihypertensive medications was noticed in females (P < 0.001), the risk of nonadherence was 1.3 times higher in males, with a relative risk of 0.883. Overall, nearly two-thirds (62.5%) of the medication nonadherence was noticed in Africans and Asians (43.5%).

Conclusion: Nonadherence to antihypertensive medications was noticed in 45% of the subjects studied and a higher proportion of uncontrolled BP (83.7%) was nonadherent to medication. Intervention models aiming to improve adherence should be emphasized.

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.


Figure 1
Figure 1
Nonadherence in hypertensive patients.
Figure 2
Figure 2
Nonadherence in hypertensive patients with comorbidities.
Figure 3
Figure 3
Nonadherence in uncontrolled hypertension patients.
Figure 4
Figure 4
Nonadherence in females and males.

Similar articles

See all similar articles

Cited by 40 articles

See all "Cited by" articles


    1. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224–60. - PMC - PubMed
    1. Burnier M. Drug adherence in hypertension. Pathophysiology and Pharmacotherapy of Cardiovascular Disease 2015;Switzerland:Springer International Publishing, 919–933.
    1. Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence for hypertension control. J Hypertens 2008;10:348–54. - PMC - PubMed
    1. Svarstad BL, Chewning BA, Sleath BL, et al. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Counsel 1999;37:113–24. - PubMed
    1. Kim MT, Hill MN, Bone LR, et al. Development and testing of the Hill-Bone Compliance to high blood pressure therapy scale. Progress Cardiovasc Nurs 2000;15:90–6. - PubMed